The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

The annual report, published online Tuesday in the Journal of the National Cancer Institute, showed this simultaneous drop in overall cancer incidence and mortality for the first ...

According to data from the National Institute on Minority Health and Health Disparities, Louisiana had the eighth-highest ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.

For decades, immune-based cancer therapies have offered hope but also risk, with powerful tumor-fighting effects often ...

A UC San Diego study reveals GLP-1 receptor agonists, like Ozempic, may significantly reduce colon cancer death rates.

A claque of online anti-vaccine influencers and dissentient researchers are claiming that COVID-19 vaccines are causing an ...

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...